STOCK TITAN

[Form 4] GoodRx Holdings, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

GoodRx Holdings (GDRX) — Form 4: Director Douglas Hirsch reported the settlement of restricted stock units into 20,521 shares of Class A common stock on 10/26/2025 under transaction code M. Following the transaction, he directly beneficially owned 231,909 Class A shares and held 41,042 RSUs as derivative securities.

The filing notes that each RSU represents the right to receive one share of Class A common stock. The RSU award vests as to one-third of the underlying shares on each of the first three anniversaries of the grant date, beginning on October 26, 2025. The report also lists indirect holdings through certain grantor retained annuity trusts, with beneficial ownership of one such trust disclaimed.

GoodRx Holdings (GDRX) — Modulo 4: Il direttore Douglas Hirsch ha riportato il perfezionamento dello scambio di unità azionarie vincolate in 20.521 azioni ordinarie di Classe A in data 26/10/2025 secondo il codice di transazione M. Dopo la transazione, possedeva direttamente come beneficiario 231.909 azioni Classe A e deteneva 41.042 RSU come strumenti derivati.

Il fascicolo segnala che ogni RSU rappresenta il diritto a ricevere una azione ordinaria di Classe A. L’assegnazione degli RSU matura per un terzo delle azioni sottostanti ad ognuna delle prime tre ricorrenze anniversarie della data di assegnazione, a partire dal 26 ottobre 2025. Il rapporto elenca inoltre detenzioni indirette tramite certi grantor retained annuity trust, con la titolarità favorevole di uno di tali trust dichiarata come non acquisita.

GoodRx Holdings (GDRX) — Formulario 4: El director Douglas Hirsch reportó la liquidación de unidades de acciones restringidas en 20.521 acciones ordinarias de Clase A en la fecha 26/10/2025 bajo el código de transacción M. Después de la operación, poseía directamente como beneficiario 231.909 acciones de Clase A y tenía 41.042 RSU como valores derivados.

El archivo señala que cada RSU representa el derecho a recibir una acción de Clase A. La adjudicación de las RSU se consolida en un tercio de las acciones subyacentes en cada uno de los primeros tres aniversarios de la fecha de otorgamiento, a partir del 26 de octubre de 2025. El informe también lista participaciones indirectas a través de ciertos trust de anualidades retenidas por el otorgante, con la titularidad beneficiosa de uno de dichos trust declarada como no reclamada.

GoodRx Holdings (GDRX) — Form 4: 더글라스 히르시 이사(Director Douglas Hirsch)가 클래스 A 보통주 20,521주2025-10-26에 코드 M로 정산했다고 보고했습니다. 거래 후 그는 클래스 A 주식 231,909주를 직접적으로 유익하게 소유했고 RSU 41,042주를 파생증권으로 보유했습니다.

공시에는 각 RSU가 하나의 클래스 A 보통주를 받을 수 있는 권리를 나타낸다고 명시되어 있습니다. RSU 상여금은 부여일로부터 처음 세 해의 기념일 중 매해 한 자리의 주당 비례로 1/3씩 취득합니다(2025년 10월 26일부터 시작). 보고서는 또한 특정 grantor retained annuity trust를 통한 간접 보유도 나열하고 있으며, 그 중 하나의 신탁에 대한 유익한 소유권은 포기가 선언되었습니다.

GoodRx Holdings (GDRX) — Formulaire 4 : Le directeur Douglas Hirsch a déclaré le règlement des unités d’actions restreintes en 20 521 actions ordinaires de Classe A le 26/10/2025 sous le code de transaction M. Suite à l’opération, il détenait directement à titre bénéfique 231 909 actions Classe A et possédait 41 042 RSU en tant que valeurs dérivées.

Le dépôt indique que chaque RSU donne droit de recevoir une action ordinaire de Classe A. L’attribution des RSU se réalise à raison d’un tiers des actions sous-jacentes lors de chacune des trois premiers anniversaires de la date d’octroi, à partir du 26 octobre 2025. Le rapport mentionne également des détentions indirectes via certains trusts d’annuités conservées par le donneur, avec la propriété bénéficiaire de l’un de ces trusts déclinée.

GoodRx Holdings (GDRX) — Form 4: Direktor Douglas Hirsch meldete die Abrechnung von Restricted-Stock-Units in 20.521 Stammaktien der Klasse A am 26.10.2025 gemäß Transaktionscode M. Nach der Transaktion besaß er direkt als vorteilhaft Berechtigter 231.909 Aktien der Klasse A und hielt 41.042 RSUs als derivative Wertpapiere.

Die Einreichung weist darauf hin, dass jede RSU das Recht zur Erhalt einer Aktie der Klasse A repräsentiert. Die RSU-Bewertung vestet in jeweils einem Drittel der zugrunde liegenden Aktien an den ersten drei Jahrestagen der Gewährungsdatum, beginnend am 26. Oktober 2025. Der Bericht listet außerdem indirekte Beteiligungen über bestimmte Grantor Retained Annuity Trusts auf, wobei der vorteilhafte Eigentum an einem der Trusts abgelehnt wurde.

GoodRx Holdings (GDRX) — النموذج 4: أبلغ المدير دوغلاس هيرش عن تسوية وحدات الأسهم المقيدة إلى 20,521 سهم من فئة أسهم Class A في 26/10/2025 بموجب رمز المعاملة M. عقب الصفقة، كان يملك مباشرةً كمستفيد 231,909 سهم من Class A ويمتلك 41,042 RSU كأوراق مالية مشتقة.

ي notes أن كل RSU يمثل حق استلام سهم واحد من Class A. يتم vesting منح RSU بنسبة ثلث الأسهم الأساسية في كل من السنوات الثلاث الأولى من تاريخ المنح، ابتداءً من 26 أكتوبر 2025. كما يذكر التقرير امتلاكاً غير مباشر من خلال بعض صناديق الثقة المعادلة التي يحتفظ بها المانِح، مع التنصل من الملكية المفيدة لأحد هذه الثقة.

Positive
  • None.
Negative
  • None.

GoodRx Holdings (GDRX) — Modulo 4: Il direttore Douglas Hirsch ha riportato il perfezionamento dello scambio di unità azionarie vincolate in 20.521 azioni ordinarie di Classe A in data 26/10/2025 secondo il codice di transazione M. Dopo la transazione, possedeva direttamente come beneficiario 231.909 azioni Classe A e deteneva 41.042 RSU come strumenti derivati.

Il fascicolo segnala che ogni RSU rappresenta il diritto a ricevere una azione ordinaria di Classe A. L’assegnazione degli RSU matura per un terzo delle azioni sottostanti ad ognuna delle prime tre ricorrenze anniversarie della data di assegnazione, a partire dal 26 ottobre 2025. Il rapporto elenca inoltre detenzioni indirette tramite certi grantor retained annuity trust, con la titolarità favorevole di uno di tali trust dichiarata come non acquisita.

GoodRx Holdings (GDRX) — Formulario 4: El director Douglas Hirsch reportó la liquidación de unidades de acciones restringidas en 20.521 acciones ordinarias de Clase A en la fecha 26/10/2025 bajo el código de transacción M. Después de la operación, poseía directamente como beneficiario 231.909 acciones de Clase A y tenía 41.042 RSU como valores derivados.

El archivo señala que cada RSU representa el derecho a recibir una acción de Clase A. La adjudicación de las RSU se consolida en un tercio de las acciones subyacentes en cada uno de los primeros tres aniversarios de la fecha de otorgamiento, a partir del 26 de octubre de 2025. El informe también lista participaciones indirectas a través de ciertos trust de anualidades retenidas por el otorgante, con la titularidad beneficiosa de uno de dichos trust declarada como no reclamada.

GoodRx Holdings (GDRX) — Form 4: 더글라스 히르시 이사(Director Douglas Hirsch)가 클래스 A 보통주 20,521주2025-10-26에 코드 M로 정산했다고 보고했습니다. 거래 후 그는 클래스 A 주식 231,909주를 직접적으로 유익하게 소유했고 RSU 41,042주를 파생증권으로 보유했습니다.

공시에는 각 RSU가 하나의 클래스 A 보통주를 받을 수 있는 권리를 나타낸다고 명시되어 있습니다. RSU 상여금은 부여일로부터 처음 세 해의 기념일 중 매해 한 자리의 주당 비례로 1/3씩 취득합니다(2025년 10월 26일부터 시작). 보고서는 또한 특정 grantor retained annuity trust를 통한 간접 보유도 나열하고 있으며, 그 중 하나의 신탁에 대한 유익한 소유권은 포기가 선언되었습니다.

GoodRx Holdings (GDRX) — Formulaire 4 : Le directeur Douglas Hirsch a déclaré le règlement des unités d’actions restreintes en 20 521 actions ordinaires de Classe A le 26/10/2025 sous le code de transaction M. Suite à l’opération, il détenait directement à titre bénéfique 231 909 actions Classe A et possédait 41 042 RSU en tant que valeurs dérivées.

Le dépôt indique que chaque RSU donne droit de recevoir une action ordinaire de Classe A. L’attribution des RSU se réalise à raison d’un tiers des actions sous-jacentes lors de chacune des trois premiers anniversaires de la date d’octroi, à partir du 26 octobre 2025. Le rapport mentionne également des détentions indirectes via certains trusts d’annuités conservées par le donneur, avec la propriété bénéficiaire de l’un de ces trusts déclinée.

GoodRx Holdings (GDRX) — Form 4: Direktor Douglas Hirsch meldete die Abrechnung von Restricted-Stock-Units in 20.521 Stammaktien der Klasse A am 26.10.2025 gemäß Transaktionscode M. Nach der Transaktion besaß er direkt als vorteilhaft Berechtigter 231.909 Aktien der Klasse A und hielt 41.042 RSUs als derivative Wertpapiere.

Die Einreichung weist darauf hin, dass jede RSU das Recht zur Erhalt einer Aktie der Klasse A repräsentiert. Die RSU-Bewertung vestet in jeweils einem Drittel der zugrunde liegenden Aktien an den ersten drei Jahrestagen der Gewährungsdatum, beginnend am 26. Oktober 2025. Der Bericht listet außerdem indirekte Beteiligungen über bestimmte Grantor Retained Annuity Trusts auf, wobei der vorteilhafte Eigentum an einem der Trusts abgelehnt wurde.

GoodRx Holdings (GDRX) — النموذج 4: أبلغ المدير دوغلاس هيرش عن تسوية وحدات الأسهم المقيدة إلى 20,521 سهم من فئة أسهم Class A في 26/10/2025 بموجب رمز المعاملة M. عقب الصفقة، كان يملك مباشرةً كمستفيد 231,909 سهم من Class A ويمتلك 41,042 RSU كأوراق مالية مشتقة.

ي notes أن كل RSU يمثل حق استلام سهم واحد من Class A. يتم vesting منح RSU بنسبة ثلث الأسهم الأساسية في كل من السنوات الثلاث الأولى من تاريخ المنح، ابتداءً من 26 أكتوبر 2025. كما يذكر التقرير امتلاكاً غير مباشر من خلال بعض صناديق الثقة المعادلة التي يحتفظ بها المانِح، مع التنصل من الملكية المفيدة لأحد هذه الثقة.

GoodRx Holdings (GDRX) — 表格 4: 董事 Douglas Hirsch 已就受限股票单位结清,转换为20,521 股甲类普通股,日期为2025-10-26,交易代码为 M。交易后,他直接以受益所有权持有231,909 股甲类股票,并以衍生证券形式持有41,042 股 RSU

文件说明每个 RSU 代表获得一股甲类普通股的权利。RSU 的授予将按前述基础股票的三分之一在授予日后的前两次周年纪念日中的每一个周年日生效,从 2025-10-26 开始。报告还列出通过某些 grantor retained annuity trust(赠与人保留年金信托)所拥有的间接持股,其中对其中一个信托的实益所有权被放弃的情况被声明。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hirsch Douglas Joseph

(Last) (First) (Middle)
C/O GOODRX HOLDINGS, INC.
2701 OLYMPIC BOULEVARD

(Street)
SANTA MONICA CA 90404

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GoodRx Holdings, Inc. [ GDRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 10/26/2025 M 20,521 A (1) 231,909 D
Class A Common Stock 2,632,721 I By CH 2024-2 GRAT(2)
Class A Common Stock 2,632,721 I By DH 2024-2 GRAT(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 10/26/2025 M 20,521 (4) (4) Class A Common Stock 20,521 $0 41,042 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
2. Share held directly by CH 2024-2 GRAT, a grantor retained annuity trust (the "CH 2024-2 GRAT"). Chona Hirsch, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the CH 2024-2 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the CH 2024-2 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.
3. Share held directly by DH 2024 -2 GRAT, a grantor retained annuity trust (the "DH 2024-2 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the DH 2024-2 GRAT.
4. The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on October 26, 2025, subject to continued service through the applicable vesting date.
Remarks:
/s/ Gracye Cheng, Attorney-in-Fact for Douglas Joseph Hirsch 10/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Goodrx Holdings, Inc.

NASDAQ:GDRX

GDRX Rankings

GDRX Latest News

GDRX Latest SEC Filings

GDRX Stock Data

1.37B
81.97M
12.67%
62.83%
1.92%
Health Information Services
Services-computer Processing & Data Preparation
Link
United States
SANTA MONICA